From Evidence to Action: Advancing Hyperkalemia Management in Chronic Kidney Disease and Heart Failure
This content is a production of Drug Topics; this Focus on Disease Supplement is supported by funding from AstraZeneca. AstraZeneca was not involved in the creation of the content for this supplement.
An interview with Ralph J. Riello III, PharmD, BCPs.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Must Guide Peptide Talks Pending FDA Action | NCPA 2026
2
FDA Approves Brytly for OTC Eye Redness Relief
3
American Pharmacists Month: Why It Matters More Than Ever
4
Q&A: Emerging Compounded Therapies Demand Pharmacist’s Clinical Judgment | NCPA 2026
5